Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Geographic Atrophy”

208 trials

Showing 20 of 208 results

Testing effectiveness (Phase 2)Ended earlyNCT02087085
What this trial is testing

A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration

Who this might be right for
Geographic AtrophyMacular Degeneration
Allergan 310
Not applicableEnded earlyNCT03935126
What this trial is testing

Global Atrophie Biomarker Evaluation Study (GABiE)

Who this might be right for
Age-related Macular Degeneration
Boehringer Ingelheim 3
Large-scale testing (Phase 3)Study completedNCT07214740
What this trial is testing

Study to Evaluate a Pegcetacoplan (Syfovre®) Prefilled Syringe

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
Apellis Pharmaceuticals, Inc. 44
Testing effectiveness (Phase 2)Study completedNCT02613572
What this trial is testing

Alpha Lipoic Acid in Geographic Atrophy

Who this might be right for
Age-Related Macular Degeneration
University of Pennsylvania 68
Large-scale testing (Phase 3)Study completedNCT04264819
What this trial is testing

Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 295
Testing effectiveness (Phase 2)WithdrawnNCT03446144
What this trial is testing

Safety and Efficacy of IONIS-FB-Lrx in up to 120 Patients 55 and Older With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Geographic AtrophyAge Related Macular Degeneration
Ionis Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT05893537
What this trial is testing

Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).

Who this might be right for
Age-Related Macular Degeneration
Cognition Therapeutics 100
Testing effectiveness (Phase 2)UnknownNCT02590692
What this trial is testing

Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD

Who this might be right for
Dry Macular DegenerationGeographic Atrophy
Regenerative Patch Technologies, LLC 16
Testing effectiveness (Phase 2)Ended earlyNCT01675947
What this trial is testing

Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy

Who this might be right for
Geographic Atrophy
National Eye Institute (NEI) 52
Large-scale testing (Phase 3)Active Not RecruitingNCT06373731
What this trial is testing

ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

Who this might be right for
Age Related Macular Degeneration (ARMD)
Stealth BioTherapeutics Inc. 313
Not applicableNot Yet RecruitingNCT05418231
What this trial is testing

Observation of the Natural Course of Age-related Macular Degeneration

Who this might be right for
Dry Age-related Macular DegenerationMacular Degeneration, Dry
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 500
Testing effectiveness (Phase 2)UnknownNCT05380492
What this trial is testing

Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-related Macular DegenerationGeographic Atrophy
Perceive Biotherapeutics, Inc. 45
Testing effectiveness (Phase 2)Study completedNCT00935883
What this trial is testing

Complement Inhibition With Eculizumab for the Treatment of Non-Exudative Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
Philip J. Rosenfeld, MD, PhD 60
Early research (Phase 1)Ended earlyNCT04002310
What this trial is testing

Test How Well Different Doses of BI 754132 Are Tolerated in Patients With an Advanced Form of Age-related Macular Degeneration Called Geographic Atrophy

Who this might be right for
Macular Degeneration
Boehringer Ingelheim 18
Testing effectiveness (Phase 2)Looking for participantsNCT06990269
What this trial is testing

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
ADARx Pharmaceuticals, Inc. 240
Testing effectiveness (Phase 2)Active Not RecruitingNCT06164587
What this trial is testing

Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy

Who this might be right for
Geographic AtrophyAge-Related Macular Degeneration
Michelle Abou-Jaoude 30
Testing effectiveness (Phase 2)Ended earlyNCT02467634
What this trial is testing

Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD

Who this might be right for
Age-Related Macular Degeneration
StemCells, Inc. 3
Testing effectiveness (Phase 2)Study completedNCT01226628
What this trial is testing

A Safety Study of CNTO 2476 in Patients With Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Janssen Research & Development, LLC 39
Testing effectiveness (Phase 2)Study completedNCT01342926
What this trial is testing

Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration

Who this might be right for
Atrophy, Geographic
GlaxoSmithKline 191
Testing effectiveness (Phase 2)Active Not RecruitingNCT06769048
What this trial is testing

Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

Who this might be right for
Geographic Atrophy
Boehringer Ingelheim 150
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation